News | August 13, 2023
Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The medical device sector is considered as one of the sunrise sectors in the country
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
